Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

African Typhimurium Lineages Adaptation Study

Project description

Understanding S. Typhimurium lineages adaptation

Salmonella enterica serovar Typhimurium ST313 Lineage 3 (L3) is a recently described pan-susceptible lineage where invasive non-typhoidal Salmonella causes about 77 500 deaths annually. This challenges the belief that antibiotic resistance is the main factor behind pathogen success. Supported by the Marie Skłodowska-Curie Actions programme, the ATLAS project will investigate why L3 thrives despite the absence of antimicrobial resistance, combining phenogenomics, functional genomics and multi-omics analyses to compare L2 and L3 isolates. By focusing on circulating L3 strains, this work will uncover L3-specific virulence mechanisms and create an open-access atlas of ST313 evolution to assess whether metabolic efficiency and immune evasion can surpass antibiotic resistance in bacterial success.

Objective

The ATLAS project tackles a critical paradox in bacterial evolution: the rise of pan-susceptible S. Typhimurium ST313 Lineage 3 (L3), which is displacing multidrug-resistant Lineage 2 (L2) across sub-Saharan Africa, a region where invasive non-typhoidal Salmonella causes around 77,500 deaths annually. This phenomenon challenges the prevailing view that antibiotic resistance is the main driver of pathogen success. Building on the host laboratory’s discovery of L3 and preliminary evidence of its hyper-replication in macrophages, ATLAS seeks to uncover why L3 thrives despite lacking antimicrobial resistance.
ATLAS employs a uniquely integrative strategy combining phenogenomics, functional genomics, and multi-omics analyses. We will compare L2 and L3 isolates using parallel workflows: phenotypic assays and pangenome analysis (WP1), coupled with dual RNA-seq, Tn-seq during macrophage infection, and integration with genome-scale metabolic models (WP2). These datasets will converge in WP3 through GWAS and a comprehensive comparative network analysis to reveal the mechanisms driving lineage replacement. This integrated approach is essential to capture the interplay of virulence, metabolism, and immune evasion, factors invisible to single-method studies.
By focusing on circulating L3 strains and applying simultaneous multi-omics integration, ATLAS moves beyond prior studies limited to early isolates and sequential analyses. Leveraging the host lab’s optimized protocols, Tn-seq libraries, and transcriptomic resources, the project will generate transformative insights: L3-specific virulence mechanisms and metabolic adaptations enabling systemic infection will be mapped, creating at the same time an open-access atlas of ST313 evolution. This resource will shift the field from descriptive observation to predictive frameworks, providing the basis to determine whether metabolic efficiency and immune evasion can outweigh antibiotic resistance in bacterial success.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-TMA-MSCA-PF-EF - HORIZON TMA MSCA Postdoctoral Fellowships - European Fellowships

See all projects funded under this funding scheme

Call for proposal

(opens in new window) HORIZON-MSCA-2025-PF

See all projects funded under this call

Coordinator

THE UNIVERSITY OF LIVERPOOL
Net EU contribution
€ 260 347,92
Address
BROWNLOW HILL 765 FOUNDATION BUILDING
L69 7ZX LIVERPOOL
United Kingdom
Region
North West (England) Merseyside Liverpool
Activity type
Higher or Secondary Education Establishments
Links
Total cost
No data